NASDAQ$AVIR

Atea Pharmaceuticals Inc · Q2 2019 earnings

Q2 2019 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.35

No prior period
Net Income

-$3.55M

No prior period
Operating Income

-$3.72M

No prior period
Gross Profit

$0.00

No prior period
R&D Expense

$2.83M

No prior period

Revenue & EPS history

Atea · Revenue · Quarterly

$0

Q2 2024
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+4.2%

Avg return

30 days after

50%

12 / 24 earnings

Positive

+16.1%

Q1 2021

Best reaction

-16.2%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2024———
Q4 2025+11.1%+15.1%+8.7%
Q3 2025-12.1%-12.9%-10.0%
Q2 2025-2.6%+1.2%-2.6%
Q1 2025+2.2%+4.0%+16.4%
Q4 2024-0.3%+3.3%-7.0%
Q3 2024-2.2%-7.0%-17.9%
Q1 2024-8.2%-9.7%-8.4%
Q4 2023-5.5%-11.4%-11.4%
Q3 2023-10.7%-14.0%-10.1%
Q2 2023+4.1%+0.3%-3.5%
Q1 2023-1.2%-3.0%+35.8%
Q4 2022-8.7%-0.8%-8.1%
Q3 2022-12.4%-14.4%-24.0%
Q2 2022-3.5%-4.3%-11.7%
Q1 2022+12.9%+36.8%+52.7%
Q4 2021+1.4%-9.7%+11.1%
Q3 2021+6.5%+6.5%-25.3%
Q2 2021-16.2%-12.9%-13.4%
Q1 2021+16.1%+18.7%+20.4%
Q2 2020+5.3%-1.4%-55.0%
Q4 2020+5.3%-1.4%-55.0%
Q1 2020+7.2%+10.6%+73.1%
Q4 2019+7.2%+10.6%+73.1%
Q3 2020+7.2%+10.6%+73.1%
Q3 2019———
Q2 2019———
Q1 2019———
Q1 2018———
Q4 2017———
Q3 2017———
Q2 2017———
Q1 2017———
Q4 2016———
Q3 2016———
Q2 2016———
Q1 2016———
Q4 2015———
Q3 2015———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro